Cantor Fitzgerald CEO Howard Lutnick argues Trump's tariff and tax plan was "amazing" for the U.S. economy while Kamala ...

The general mood among these heavyweight investors is divided, with 21% leaning bullish and 71% bearish. Among these notable ...

Louise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk's CEO on Capitol Hill, when drug ...

Sabre Corp (SABR) stock saw a modest uptick, ending the day at $3.29 which represents a slight increase of $0.07 or 2.17% from the prior close of $3.22. The stock opened at $3.22 and touched a low of ...

Fintel reports that on September 23, 2024, Cantor Fitzgerald downgraded their outlook for 4D Molecular Therapeutics (NasdaqGS ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.15% of ...

Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group, is breaking into ...

Cantor Fitzgerald analyst Pete Stavropoulos maintained a Buy rating on Vera Therapeutics (VERA – Research Report) yesterday and set a ...

In a report released on September 20, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Nano-X Imaging (NNOX – Research ...